Zacks Investment Research on MSN
Will Defencath continue to aid CorMedix's top line in Q4 earnings?
CorMedix’s CRMD lead product, DefenCath (taurolidine plus heparin), is the company’s primary source of revenues. DefenCath ...
Up to 189 health conditions could potentially affect your ability to drive, with seven specific conditions that must be ...
As many as 189 health conditions could potentially affect your legal ability to drive. Both physical and mental health ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results